Loading articles...

Vancouver based research company receiving $175-million federal support in efforts to treat COVID-19

Last Updated May 3, 2020 at 11:39 am PDT

FILE - In this March 11, 2020 file photo, a technician prepares COVID-19 coronavirus patient samples for testing at a laboratory in New York's Long Island. THE ASSOCIATED PRESS/John Minchillo
Summary

Vancouver based AbCellera Biologics is receiving $175-million in federal support

Funding the research company is an effort to treat COVID-19

OTTAWA (NEWS 1130) — The federal government is pouring millions of dollars into a Vancouver-based bio-research company, which is looking into the treatment and prevention of COVID-19.

$175-million to AbCellera Biologics was announced by Prime Minister Justin Trudeau during his daily update from Ottawa Sunday morning.

He said the company is doing a “very promising” work around COVID-19.

“They’ve identified antibodies that could be used in drugs to treat this virus. This new funding will help them continue their vital work, and will support human [trials].”

Trials will begin as early as July.

In addition to the federal support, the City of Vancouver is “ensuring AbCellera has the infrastructure needed as they accelerate finding a treatment for COVID-19,” Vancouver Mayor Kennedy Stewart says in a release published by AbCellera.

“We couldn’t be more proud to be on the front lines of this global effort thanks to the innovation and leadership of AbCellera,” Stewart adds.

During Trudeau’s Sunday briefing, he said, although while Canadians wait for effective treatments or a vaccine, “we still need a reliable supply of everything from masks to ventilators.”